ENTITY

Automera Pte Ltd (2308524D SP)

Analysis

Health Care • Singapore

Automera Pte. Ltd. operates as a biotechnology company. The Company focuses on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera serves customers in the United States and Singapore.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00